NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,275.00
+278.00 (13.92%)
At close: Aug 11, 2026

NGeneBio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,9691,9434,43019,27524,89716,296
Short-Term Investments
959.38707.458.42129.0510,0218,011
Trading Asset Securities
2,4853,0253,0083,023--
Cash & Short-Term Investments
6,4135,6757,49622,42734,91824,307
Cash Growth
28.01%-24.30%-66.57%-35.77%43.66%-
Accounts Receivable
12,19613,847699.76788.951,1251,574
Other Receivables
277.1872.9862.06210.7751.0958.06
Receivables
12,98114,428761.82999.721,1761,632
Inventory
1,5901,4232,0741,6952,9681,219
Prepaid Expenses
141.27366.84120.57121.5141.7279.67
Other Current Assets
2,1472,4831,2201,7793,868136.73
Total Current Assets
23,27224,37711,67227,02143,07227,374
Property, Plant & Equipment
6,9666,42912,1729,3438,6848,092
Long-Term Investments
1,9621,9051,0572,8371,3785,451
Goodwill
3,1702,9835,388416.32416.32416.32
Other Intangible Assets
2,0061,9892,4271,4561,2241,247
Other Long-Term Assets
34,31734,655233.051,2081,3891,287
Total Assets
71,69372,33832,95042,28256,16443,867

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,3955,140376.67162.7569.18172.85
Accrued Expenses
707.52557.94476.88253.59235.99188.37
Short-Term Debt
32,25232,7776,75011,05610,7866,100
Current Portion of Long-Term Debt
-----362
Current Portion of Leases
319.16318.521,028241.11295.95161.89
Current Unearned Revenue
-0.04-020.1718.33
Other Current Liabilities
9,5499,2133,89312,10317,5941,051
Total Current Liabilities
48,22348,00612,52523,81629,0018,055
Long-Term Debt
-----500
Long-Term Leases
109.19153.451,242146.88374.6282.69
Pension & Post-Retirement Benefits
1,1131,0881,4651,9351,2971,188
Other Long-Term Liabilities
127.65497.7710.19150.52165.3843.69
Total Liabilities
49,57249,74515,24126,04830,8379,869

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
26,81025,03819,81912,88912,52612,431
Additional Paid-In Capital
70,97169,03560,90955,10252,57051,982
Retained Earnings
-75,852-71,661-66,297-53,941-40,886-31,381
Comprehensive Income & Other
639.9554.092,5472,2441,086965.73
Total Common Equity
22,56922,96616,97716,29525,29733,998
Minority Interest
-447.78-373.77731.71-60.6830.24-
Shareholders' Equity
22,12122,59217,70916,23425,32733,998
Total Liabilities & Equity
71,69372,33832,95042,28256,16443,867

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
32,68133,2499,01911,44411,4567,207
Net Cash (Debt)
-26,267-27,574-1,52310,98323,46217,100
Net Cash Growth
----53.19%37.20%-
Net Cash Per Share
-3277.86-3678.51-322.182597.565640.724147.91
Filing Date Shares Outstanding
8.948.356.614.34.184.14
Total Common Shares Outstanding
8.948.356.614.34.184.14
Working Capital
-24,950-23,630-852.153,20514,07219,319
Book Value Per Share
2525.412751.752569.873792.666058.748204.81
Tangible Book Value
17,39317,9949,16214,42223,65632,334
Tangible Book Value Per Share
1946.232156.021386.833356.845665.847803.33
Land
1,9291,9292,6962,6962,5842,584
Buildings
2,8932,8934,0444,0443,0403,040
Machinery
7,3936,8908,4224,9624,5693,699
Construction In Progress
----9.23-